All Updates

All Updates

icon
Filter
Partnerships
Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training
Psychedelic Medicine
May 21, 2024
This week:
Geographic expansion
Partnerships
Lemonade partners with Homesite to expand home insurance services
InsurTech: Personal Lines
Jun 14, 2024
Funding
BayaniPay raises USD 3 million in seed funding to expand payment solutions
Neobanks
Jun 14, 2024
Partnerships
Carbonfuture and Swiss Re partner for long-term carbon removal through biochar
Carbon Management Software
Jun 13, 2024
Funding
Sidekick raises GBP 8.5 million in seed and debt funding to support expansion
Retail Trading Infrastructure
Jun 13, 2024
Partnerships
Climatiq and Epicor partner to reduce CO2 emissions in supply chains
Carbon Management Software
Jun 13, 2024
Product updates
EHang's pilotless eVTOL aircraft concludes first flight launch in Saudi Arabia
Passenger eVTOL Aircraft
Jun 13, 2024
Partnerships
Skyports partners with Unified Aviation to accelerate global network release
Passenger eVTOL Aircraft
Jun 13, 2024
Industry news
Partnerships
USSF chooses Blue Origin, SpaceX, and ULA for ~USD 5.6 billion Pentagon launch contracts
Space Travel and Exploration Tech
Jun 13, 2024
Funding
AnyCreek raises USD 1.8 million in seed funding to enhance platform and expand into new markets
Travel Tech
Jun 13, 2024
Funding
Zeta Labs raises USD 2.9 million in pre-seed funding to develop autonomous AI agent
Generative AI Applications
Jun 13, 2024
Psychedelic Medicine

Psychedelic Medicine

May 21, 2024

Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training

Partnerships

  • Fluence, a company specializing in psychedelic therapy training, has partnered with Metamorph AI, a technology company, to develop a GenAI tool for psychedelic therapy training.

  • The tool analyzes therapist role-play sessions, identifies areas for improvement, and provides actionable feedback by highlighting missed therapeutic opportunities, flagging deeper engagement possibilities, and generating self-assessment reports. It's integrated into Fluence’s training program to boost training efficiency, and therapy effectiveness while reducing review time for instructors.

  • Analyst QuickTake: Fluence has established several partnerships within the psychedelic industry, including Reunion Neuroscience (April 2024), Psyence (April 2024), Cybin (September 2023), and Tryp Therapeutics (May 2021). The latest partnership with Metamorph AI is expected to enhance the landscape of psychedelic therapy training.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.